Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study.

ABSTRACT: BACKGROUND:In October 2012, the Chinese government established maximum retail prices for specific products, including 30 antineoplastic medications. Three years later, in June 2015, the government abolished price regulation for most medications, including all antineoplastic medications. This study examined the impacts of regulation and subsequent deregulation of prices of antineoplastic medications in China. METHODS:Using hospital procurement data and an interrupted time series with comparison series design, we examined the impacts of the policy changes on relative purchase prices (Laspeyres price index) and volumes of and spending on 52 antineoplastic medications in 699 hospitals. We identified three policy periods: prior to the initial price regulation (October 2011 to September 2012); d

SUBMITTER: Guan X 

PROVIDER: S-EPMC6924745 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature